Julian Sanchez, MD

Cancer Focus:
Anal Cancer, Appendiceal (Appendix) Cancer, Colon Cancer, Colorectal Cancer, Rectal Cancer, Small Intestine Cancer

Julian Sanchez, MD, is a board-certified colorectal surgeon, Senior Member, Professor of Surgery, and Leader of the Colorectal Oncology Section at Moffitt Cancer Center. He specializes in the multidisciplinary management of colon cancer, rectal cancer, and anal cancer, with a dedicated focus on cancer prevention, early detection, and advanced surgical care.

Dr. Sanchez serves as Director of the Hereditary Colorectal Cancer Clinic and Director of the Anal Dysplasia Clinic, leading nationally recognized programs devoted to patients with inherited cancer syndromes and HPV-related anal disease. In these roles, he collaborates with experts in gastroenterology, medical oncology, radiation oncology, pathology, and genetics to deliver comprehensive, evidence-based care to high-risk patient populations.

Dr. Sanchez earned his medical degree from Tufts School of Medicine and completed General Surgery Residency at the University of South Florida, followed by fellowship training in Colorectal Surgery at Cleveland Clinic. His academic and clinical training emphasize minimally invasive and oncologic colorectal surgery, complex multidisciplinary cancer care, and the integration of research into clinical practice.

As a physician–scientist, Dr. Sanchez has an established research program focused on HPV-associated anal disease and cancer prevention. His work centers on anal intraepithelial neoplasia (AIN) and strategies to reduce the burden of anal cancer, particularly among individuals living with HIV. Dr. Sanchez is an expert in High Resolution Anoscopy (HRA) and leads institutional efforts in advanced anal cancer screening. He performs HRA with targeted biopsies and therapeutic ablation, providing precise, minimally invasive treatment of precancerous lesions with the goal of preventing progression to invasive malignancy.

Dr. Sanchez also has extensive expertise in the management of hereditary colorectal cancer syndromes, including Lynch syndrome and familial adenomatous polyposis (FAP). Through the Hereditary Colorectal Cancer Clinic, he provides genetic risk assessment, individualized surveillance strategies, and preventive surgical management for patients and families at increased risk of colorectal cancer.

Dr. Sanchez is board certified by the American Board of Colon and Rectal Surgery and has been an active member of the Society of Surgical Oncology (SSO), the American Society of Colon and Rectal Surgeons (ASCRS), and the International Anal Neoplasia Society (IANS). He participates in national and international professional collaborations focused on advancing colorectal cancer care, HPV-related disease management, and evidence-based screening guidelines. Dr. Sanchez serves on expert advisory panels and multidisciplinary working groups dedicated to improving standards for anal cancer prevention, hereditary colorectal cancer management, and comprehensive oncologic care.

Dr. Sanchez believes that exceptional cancer care requires both technical excellence and compassionate, individualized attention. He emphasizes shared decision-making, clear communication, and a multidisciplinary approach tailored to each patient’s medical needs and personal goals. By integrating leading-edge science with a deeply humanistic approach to care, Dr. Sanchez strives to support patients and families throughout diagnosis, treatment, and survivorship.

Dr. Sanchez is accepting new patients.  Surgical consultation can be seen within one week.  No referral is needed.  

 

Education & Training

Fellowship:

• Cleveland Clinic, Ohio - Colorectal Surgery

Residency:

• University of South Florida - General Surgery

Medical School:

• Tufts University School of Medicine - MD

• Christy SM, Sutton SK, Owens H, Trejos RF, Arevalo M, Meade CD, Lopez J, Sanders LJ, Vadaparampil ST, Park E, Ramos-Sepúlveda M, Borrego-Villanueva J, Patra C, Sanchez J, Marzán-Rodríguez M. Human papillomavirus vaccine knowledge, health beliefs, recommendation receipt, and intentions among Spanish-speaking Hispanic/Latino sexual and gender minority young adults assigned male at birth in Florida and Puerto Rico: results of a cross-sectional s. Ethn Health. 2026 May.31(4):263-281. Pubmedid: 41576421. Pmcid: PMC13048128.
• Radosavljevic I, Dam A, Luthra AK, Pena L, Cappelle S, Permuth JB, Felder S, Sanchez J, Stefanou A, Friedman M, Mok SR. Assessing outcomes of full-thickness resection in piecemeal polypectomy scar consolidation of colon adenomas containing cancer. Endosc Int Open. 2025 Sep.13:a26372047. Pubmedid: 40932816. Pmcid: PMC12417760.
• Shannon AB, Laronga C, Balsay-Patel C, Barton LV, Pena L, Lee MC, Sanchez JA, Pimiento JM, Felder SI, Sinnamon AJ. Premalignant Colorectal Adenoma Detection in Individuals with Inherited CDH1 Genetic Mutations: A Single-Institution Experience. South Med J. 2025 Oct.118(10):692-697. Pubmedid: 41072036.
• Hendrick LE, Naffouje S, Imanirad I, Pereira AL, Biachi T, Sanchez J, Dessureault S, Stefanou A, Dineen SP, Felder S. Incomplete Resection Is Twice as Likely in Locally Advanced Mucinous Compared to Nonmucinous Rectal Adenocarcinoma: A National Propensity-Matched Analysis. J Surg Oncol. 2025 May.131(6):1090-1100. Pubmedid: 39658830.
• Matejcic M, Teer JK, Hoehn HJ, Diaz DB, Shankar K, Gong J, Nguyen NT, Loroña NC, Coppola D, Fulmer CG, Saglam O, Jiang K, Cress WD, Muñoz-Antonia T, Flores I, Gordián ER, Oliveras Torres JA, Felder SI, Sanchez J, Fleming JB, Siegel EM, Freedman JA, Dutil J, Stern MC, Fridley BL, Figueiredo JC, Schmit SL. Colorectal Tumors in Diverse Patient Populations Feature a Spectrum of Somatic Mutational Profiles. Cancer Res. 2025 May.85(10):1928-1944. Pubmedid: 40126181. Pmcid: PMC12234169.
• Guske C, Immen N, Conant D, Laborde J, Linscott J, Hayes M, Jazayeri SB, Fazili A, Siegel E, Dessureault S, Sanchez J, Stefanou A, Manley B, Felder S. Short- and Intermediate-Term Morbidity Following Total Pelvic Exenteration in Colorectal Cancer. Cancer Control. 2025 Jan.32:10732748251316598. Pubmedid: 39848249. Pmcid: PMC11758541.
• Villalona S, Sanchez J, Mangkalard P, Best AL. Understanding Disclosure Decisions and Communication About HPV-Related Cancer: A Qualitative Exploration of Stigma and Social Support. Healthcare (Basel). 2025 Apr.13(9). Pubmedid: 40361744. Pmcid: PMC12071953.
• Schmit SL, Loroña NC, Sobieski D, Matejcic M, Nguyen NT, Hoehn HJ, Diaz DB, Shankar K, Cockman EM, Jean-Baptiste E, Tsai YY, Buchalter RB, Brito K, Wilson R, Coppola D, Fulmer C, Saglam O, Tassielli AF, Beato F, Dai R, Freedman JA, Purrington K, Hu B, Mcgrail D, Gibson H, Jiang K, Muñoz-Antonia T, Flores I, Gordian E, Oliveras Torres JA, Cheng I, Van Blarigan EL, Felder SI, Sanchez JA, Fleming JB, Siegel EM, Cress D, Thompson P, Stern MC, Teer JK, Figueiredo JC. Building research infrastructure to advance precision medicine in colorectal cancer. JNCI Cancer Spectr. 2025 Apr.9(3). Pubmedid: 40111849. Pmcid: PMC12140009.
• Suk-Ouichai C, Coghill AE, Schabath MB, Sanchez JA, Chahoud J, Necchi A, Giuliano AR, Spiess PE. A clinical overview of people living with HIV and genitourinary cancer care. Nat Rev Urol. 2024 Jun.21(6):373-383. Pubmedid: 38238527.
• Ogunleye O, Feuerlein S, Ahmed A, Parsee A, Jeong D, Henning J, Frakes J, Stefanou A, Sanchez J, Hoffe S, Dessureault S, Felder S, Costello J. The role of rectal magnetic resonance imaging in accurate localization and designation of colorectal cancer for optimal management: Case study. Radiol Case Rep. 2024 Aug.19(8):3042-3048. Pubmedid: 38745979. Pmcid: PMC11091459.
• Pointer DT, Felder SI, Powers BD, Dessureault S, Sanchez JA, Imanirad I, Sahin I, Xie H, Naffouje SA. Return to intended oncologic therapy after colectomy for stage III colon adenocarcinoma: Does surgical approach matter?. Colorectal Dis. 2023 Sep.25(9):1760-1770. Pubmedid: 37553808.
• Stefanou AJ, Dessureault S, Sanchez J, Felder S. Clinical Tools for Rectal Cancer Response Assessment following Neoadjuvant Treatment in the Era of Organ Preservation. Cancers (Basel). 2023 Nov.15(23). Pubmedid: 38067239.
• Tang J, Wong G, Naffouje S, Felder S, Sanchez J, Dineen S, Powers BD, Dessureault S, Gurd E, Castillo D, Hodul P. A Novel Nomogram for Early Identification and Intervention in Colorectal Cancer Patients at Risk for Malnutrition. Am Surg. 2023 May.89(5):1485-1496. Pubmedid: 34920671.
• Kano M, Tamí-Maury I, Pratt-Chapman ML, Chang S, Kosich M, Quinn GP, Poteat T, Kanetsky PA, Elk R, Boehmer U, Sanchez J, Kamen C, Sanchez NF. Piloting the Sexual and Gender Minority Cancer Curricular Advances for Research and Education (SGM Cancer CARE) Workshop: Research Training in the Service of SGM Cancer Health Equity. J Cancer Educ. 2023 Jun.38(3):1066-1076. Pubmedid: 36399283. Pmcid: PMC9673892.
• Himbert C, Ose J, Gigic B, Viskochil R, Santuci K, Lin T, Ashworth A, Cohan JN, Scaife CL, Jedrzkiewicz J, Damerell V, Atkins KM, Gong J, Mutch MG, Bernadt C, Felder S, Sanchez J, Cohen SA, Krane MK, Hinkle N, Wood E, Peoples AR, Figueiredo JC, Toriola AT, Siegel EM, Li CI, Shibata D, Boucher K, Round JL, Ulrich AB, Schneider M, Huang LC, Hardikar S, Ulrich CM. Associations of combined physical activity and body mass index groups with colorectal cancer survival outcomes. BMC Cancer. 2023 Apr.23(1):300. Pubmedid: 37013476. Pmcid: PMC10069054.
• Chavarria EA, Christy SM, Feng H, Miao H, Abdulla R, Gutierrez L, Lopez D, Sanchez J, Gwede CK, Meade CD. Online Health Information Seeking and eHealth Literacy Among Spanish Language-Dominant Latino Adults Receiving Care in a Community Clinic: Secondary Analysis of Pilot Randomized Controlled Trial Data. JMIR Form Res. 2022 Oct.6(10):e37687. Pubmedid: 35238785. Pmcid: PMC9614617.
• Coghill A, Sanchez J, Sinha S, Permuth JB, Laskowitz D, Powers BD, Dineen SP. Safe performance of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with HIV infection. Cancer Rep (Hoboken). 2022 Oct.5(10):e1667. Pubmedid: 35869601. Pmcid: PMC9575487.
• Christy SM, Sutton SK, Abdulla R, Boxtha C, Gonzalez P, Cousin L, Ewing A, Montoya S, Lopez D, Beehler T, Sanchez J, Carvajal R, Meade CD, Gwede CK. A multilevel, low literacy dual language intervention to promote colorectal cancer screening in community clinics in Florida: A randomized controlled trial. Prev Med. 2022 May.158:107021. Pubmedid: 35305995. Pmcid: PMC9018599.
• Naffouje SA, Lauwers G, Klapman J, Dam A, Pena L, Friedman M, Sanchez J, Dessureault S, Felder S. Malignant colon polyps: predicting lymph node metastasis following endoscopic excision. Int J Colorectal Dis. 2022 Feb.37(2):393-402. Pubmedid: 35001147.
• Naffouje SA, Manguso N, Imanirad I, Sahin IH, Xie H, Hoffe S, Frakes J, Sanchez J, Dessureault S, Felder S. Neoadjuvant rectal score is prognostic for survival: A population-based propensity-matched analysis. J Surg Oncol. 2022 Dec.126(7):1219-1231. Pubmedid: 35916542.
• Mills MN, Naz A, Sanchez J, Dessureault S, Imanirad I, Lauwers G, Moore M, Hoffe S, Frakes J, Felder S. Rectal tumor fragmentation as a response pattern following chemoradiation. J Gastrointest Oncol. 2022 Dec.13(6):2951-2962. Pubmedid: 36636056. Pmcid: PMC9830359.
• Mehta R, Frakes J, Kim J, Nixon A, Liu Y, Howard L, Martinez Jimenez ME, Carballido E, Imanirad I, Sanchez J, Dessureault S, Xie H, Felder S, Sahin I, Hoffe S, Malafa M, Kim R. Phase I Study of Lenvatinib and Capecitabine with External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma. Oncologist. 2022 Aug.27(8):621-e617. Pubmedid: 35325225. Pmcid: PMC9355805.
• Naffouje S, Sabesan A, Powers BD, Dessureault S, Sanchez J, Schell M, Imanirad I, Sahin I, Xie H, Felder S. Patient Risk Subgroups Predict Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer Patients Following Neoadjuvant Chemoradiation and Total Mesorectal Excision. Clin Colorectal Cancer. 2021 Sep.20(3):e155-e164. Pubmedid: 33775560.
• Christy SM, Cousin LA, Sutton SK, Chavarria EA, Abdulla R, Gutierrez L, Sanchez J, Lopez D, Gwede CK, Meade CD. Characterizing Health Literacy Among Spanish Language-Preferring Latinos Ages 50-75. Nurs Res. 2021 Sep.70(5):344-353. Pubmedid: 33990120. Pmcid: PMC8405461.
• Felder SI, Feuerlein S, Parsee A, Imanirad I, Sanchez J, Dessureault S, Kim R, Hoffe S, Frakes J, Costello J. Endoscopic and MRI response evaluation following neoadjuvant treatment for rectal cancer: a pictorial review with matched MRI, endoscopic, and pathologic examples. Abdom Radiol (NY). 2021 May.46(5):1783-1804. Pubmedid: 33111189.
• Dohm A, Sanchez J, Stotsky-Himelfarb E, Willingham FF, Hoffe S. Strategies to Minimize Late Effects From Pelvic Radiotherapy. Am Soc Clin Oncol Educ Book. 2021 Mar.41:158-168. Pubmedid: 34010045.
• Himbert C, Figueiredo JC, Shibata D, Ose J, Lin T, Huang LC, Peoples AR, Scaife CL, Pickron B, Lambert L, Cohan JN, Bronner M, Felder S, Sanchez J, Dessureault S, Coppola D, Hoffman DM, Nasseri YF, Decker RW, Zaghiyan K, Murrell ZA, Hendifar A, Gong J, Firoozmand E, Gangi A, Moore BA, Cologne KG, El-Masry MS, Hinkle N, Monroe J, Mutch M, Bernadt C, Chatterjee D, Sinanan M, Cohen SA, Wallin U, Grady WM, Lampe PD, Reddi D, Krane M, Fichera A, Moonka R, Herpel E, Schirmacher P, Kloor M, von Knebel-Doeberitz M, Nattenmueller J, Kauczor HU, Swanson E, Jedrzkiewicz J, Schmit SL, Gigic B, Ulrich AB, Toriola AT, Siegel EM, Li CI, Ulrich CM, Hardikar S. Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset. Cancers (Basel). 2021 Jul.13(15). Pubmedid: 34359718. Pmcid: PMC8345133.
• Shindorf ML, Copeland AR, Gupta S, Steinberg SM, Steele SR, Yeo HL, Sanchez JA, Hernandez JM. Evaluation of Factors Associated With Successful Matriculation to Colon and Rectal Surgery Fellowship. Dis Colon Rectum. 2021 Feb.64(2):234-240. Pubmedid: 33315718. Pmcid: PMC9161349.
• Yuan Z, Frazer M, Rishi A, Latifi K, Tomaszewski MR, Moros EG, Feygelman V, Felder S, Sanchez J, Dessureault S, Imanirad I, Kim RD, Harrison LB, Hoffe SE, Zhang GG, Frakes JM. Pretreatment CT and PET radiomics predicting rectal cancer patients in response to neoadjuvant chemoradiotherapy. Rep Pract Oncol Radiother. 2021 Feb.26(1):29-34. Pubmedid: 33948299. Pmcid: PMC8086711.
• Dhahri A, Kaplan J, Naqvi SMH, Brownstein NC, Ntiri SO, Imanirad I, Felder SI, Dineen SP, Sanchez J, Dessureault S, Carballido E, Powers BD. The impact of socioeconomic status on survival in stage III colon cancer patients: A retrospective cohort study using the SEER census-tract dataset. Cancer Med. 2021 Aug.10(16):5643-5652. Pubmedid: 34197047. Pmcid: PMC8366079.
• Sutter ME, Simmons VN, Sutton SK, Vadaparampil ST, Sanchez JA, Bowman-Curci M, Duarte L, Schabath MB, Quinn GP. Oncologists' experiences caring for LGBTQ patients with cancer: Qualitative analysis of items on a national survey. Patient Educ Couns. 2021 Apr.104(4):871-876. Pubmedid: 32981814. Pmcid: PMC7982350.
• Yuan Z, Frazer M, Ahmed KA, Naqvi SMH, Schell MJ, Felder S, Sanchez J, Dessureault S, Imanirad I, Kim RD, Torres-Roca JF, Hoffe SE, Frakes JM. Modeling precision genomic-based radiation dose response in rectal cancer. Future Oncol. 2020 Oct.16(30):2411-2420. Pubmedid: 32686956.
• Frazer ML, Yang G, Felder S, McDonald J, Sanchez J, Dessureault S, Imanirad I, Carballido E, Kim RD, Hoffe SE, Frakes JM. Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation. Am J Clin Oncol. 2020 May.43(5):319-324. Pubmedid: 32028341.
• Yuan Z, Frazer M, Zhang GG, Latifi K, Moros EG, Feygelman V, Felder S, Sanchez J, Dessureault S, Imanirad I, Kim RD, Harrison LB, Hoffe SE, Frakes JM. CT-based radiomic features to predict pathological response in rectal cancer: A retrospective cohort study. J Med Imaging Radiat Oncol. 2020 Jun.64(3):444-449. Pubmedid: 32386109.
• Berry-Lawhorn JM, Sanchez JA. Now Is the Time to Work Together!. Dis Colon Rectum. 2019 Sep.62(9):e413. Pubmedid: 31397755.
• Schabath MB, Blackburn CA, Sutter ME, Kanetsky PA, Vadaparampil ST, Simmons VN, Sanchez JA, Sutton SK, Quinn GP. National Survey of Oncologists at National Cancer Institute-Designated Comprehensive Cancer Centers: Attitudes, Knowledge, and Practice Behaviors About LGBTQ Patients With Cancer. J Clin Oncol. 2019 Mar.37(7):547-558. Pubmedid: 30650044. Pmcid: PMC6553841.
• Gwede CK, Sutton SK, Chavarria EA, Gutierrez L, Abdulla R, Christy SM, Lopez D, Sanchez J, Meade CD. A culturally and linguistically salient pilot intervention to promote colorectal cancer screening among Latinos receiving care in a Federally Qualified Health Center. Health Educ Res. 2019 Jun.34(3):310-320. Pubmedid: 30929015. Pmcid: PMC7868960.
• Reid E, Suneja G, Ambinder RF, Ard K, Baiocchi R, Barta SK, Carchman E, Cohen A, Crysler OV, Gupta N, Gustafson C, Hall A, Johung KL, Klopp A, LaCasce AS, Lin C, Mehta A, Menon MP, Morgan D, Nathwani N, Noy A, Ratner L, Rizza S, Rudek MA, Sanchez J, Taylor J, Tomlinson B, Wang CJ, Yendamuri S, Dwyer MA, Freedman-Cass DA. AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Ne. 2019 Feb.17(2):171-189. Pubmedid: 30787130.
• Wheldon CW, Schabath MB, Hudson J, Bowman Curci M, Kanetsky PA, Vadaparampil ST, Simmons VN, Sanchez JA, Sutton SK, Quinn GP. Culturally Competent Care for Sexual and Gender Minority Patients at National Cancer Institute-Designated Comprehensive Cancer Centers. LGBT Health. 2018 Apr.5(3):203-211. Pubmedid: 29641317. Pmcid: PMC5905865.
• Tamargo CL, Quinn GP, Sanchez JA, Schabath MB. Cancer and the LGBTQ Population: Quantitative and Qualitative Results from an Oncology Providers' Survey on Knowledge, Attitudes, and Practice Behaviors. J Clin Med. 2017 Oct.6(10). Pubmedid: 28991160. Pmcid: PMC5664008.
• Hudson J, Schabath MB, Sanchez J, Sutton S, Simmons VN, Vadaparampil ST, Kanetsky PA, Quinn GP. Sexual and Gender Minority Issues Across NCCN Guidelines: Results From a National Survey. J Natl Compr Canc Ne. 2017 Nov.15(11):1379-1382. Pubmedid: 29118229. Pmcid: PMC5705047.
• Schabath MB, Curci MB, Kanetsky PA, Vadaparampil ST, Simmons VN, Sanchez JA, Sutton SK, Wheldon C, Quinn GP. Ask and Tell: The Importance of the Collection of Sexual Orientation and Gender Identity Data to Improve the Quality of Cancer Care for Sexual and Gender Minorities. J Oncol Pract. 2017 Aug.13(8):542-546. Pubmedid: 28719237.
• Shetty G, Sanchez JA, Lancaster JM, Wilson LE, Quinn GP, Schabath MB. Oncology healthcare providers' knowledge, attitudes, and practice behaviors regarding LGBT health. Patient Educ Couns. 2016 Oct.99(10):1676-1684. Pubmedid: 27161166. Pmcid: PMC5527558.
• Hanna C, Mullinax J, Friedman MS, Sanchez J. Jejunal diverticulosis found in a patient with long-standing pneumoperitoneum and pseudo-obstruction on imaging: a case report. Gastroenterol Rep (Oxf). 2016 Nov.4(4):337-340. Pubmedid: 26220890. Pmcid: PMC5193057.
• Seydafkan S, Shibata D, Sanchez J, Tran ND, Leon M, Coppola D. Pathology Report: Presacral Noncommunicating Enteric Duplication Cyst. Cancer Control. 2016 Apr.23(2):170-174. Pubmedid: 27218796.
• Chen YJ, Chen MB, Liu AJ, Sanchez J, Tsai P, Liu A. Dosimetric coverage of the external anal sphincter by 3-dimensional conformal fields in rectal cancer patients receiving neoadjuvant chemoradiation: implications for the concept of sphincter-preserving radiation therapy. Biomed Res Int. 2015 Sep.2014:578243. Pubmedid: 25089274. Pmcid: PMC4095991.
• Quinn GP, Sanchez JA, Sutton SK, Vadaparampil ST, Nguyen GT, Green BL, Kanetsky PA, Schabath MB. Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA-Cancer J Clin. 2015 Dec.65(5):384-400. Pubmedid: 26186412. Pmcid: PMC4609168.
• Quinn GP, Schabath MB, Sanchez JA, Sutton SK, Green BL. The importance of disclosure: lesbian, gay, bisexual, transgender/transsexual, queer/questioning, and intersex individuals and the cancer continuum. Cancer. 2015 Apr.121(8):1160-1163. Pubmedid: 25521303. Pmcid: PMC4505934.
• Patel SS, Nelson R, Sanchez J, Lee W, Uyeno L, Garcia-Aguilar J, Hurria A, Kim J. Elderly patients with colon cancer have unique tumor characteristics and poor survival. Cancer. 2013 Feb.119(4):739-747. Pubmedid: 23011893.
• Arrington AK, Heinrich EL, Lee W, Duldulao M, Patel S, Sanchez J, Garcia-Aguilar J, Kim J. Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer. Int J Mol Sci. 2012 Sep.13(10):12153-12168. Pubmedid: 23202889 . Pmcid: PMC3497263.
• Arrington AK, Heinrich EL, Lee W, Duldulao M, Patel S, Sanchez J, Garcia-Aguilar J, Kim J. Prognostic and predictive roles of KRAS mutation in colorectal cancer. Int J Mol Sci. 2012 Sep.13(10):12153-12168. Pubmedid: 23202889. Pmcid: PMC3497263.
• Kalady MF, Dejulius KL, Sanchez JA, Jarrar A, Liu X, Manilich E, Skacel M, Church JM. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis. Dis Colon Rectum. 2012 Feb.55(2):128-133. Pubmedid: 22228154.
• Sanchez JA, Dejulius KL, Bronner M, Church JM, Kalady MF. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Inflamm Bowel Dis. 2011 Sep.17(9):1966-1970. Pubmedid: 21618350.
• Sanchez JA, Dejulius KL, Bronner M, Church JM, Kalady MF. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Inflamm Bowel Dis. 2011 Sep.17(9):1966-1970. Pubmedid: 21618350.
• Messick CA, Sanchez J, Dejulius KL, Hammel J, Ishwaran H, Kalady MF. CEACAM-7: a predictive marker for rectal cancer recurrence. Surgery. 2010 May.147(5):713-719. Pubmedid: 20004437.
• Messick CA, Sanchez J, Dejulius KL, Hammel J, Ishwaran H, Kalady MF. CEACAM-7: a predictive marker for rectal cancer recurrence. Surgery. 2010 May.147(5):713-719. Pubmedid: 20004437.
• Sanchez JA, Krumroy L, Plummer S, Aung P, Merkulova A, Kalady MF, DeJulius KL, Manilich E, Church JM, Casey G, Skacel M. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer. Br J Surg. 2009 Oct.96(10):1196-1204. Pubmedid: 19787768.
• Kalady MF, Sanchez JA, Manilich E, Hammel J, Casey G, Church JM. Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas. Dis Colon Rectum. 2009 Jun.52(6):1039-1045. Pubmedid: 19581844.
• Messick CA, Sanchez J, Dejulius KL, Church JM, Kalady MF. Genetic and molecular diversity of colon cancer hepatic metastases. Surgery. 2009 Aug.46(2):227-231. Pubmedid: 19628078.
• Fukuyama R, Niculaita R, Ng KP, Obusez E, Sanchez J, Kalady M, Aung PP, Casey G, Sizemore N. Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription. Oncogene. 2008 Oct.27(46):6044-6055. Pubmedid: 18591935. Pmcid: PMC2574581.
• Sanchez JA, Vogel JD, Kalady MF, Bronner MP, Skacel M, Church JM. Identifying Lynch syndrome: we are all responsible. Dis Colon Rectum. 2008 Dec.51(12):1750-1756. Pubmedid: 18682882.
• Sanchez JA, Vogel JD, Kalady MF, Bronner MP, Skacel M, Church JM. Identifying Lynch syndrome: we are all responsible. Dis Colon Rectum. 2008 Dec.51(12):1750-1756. Pubmedid: 18682882.

• Title: Health Equity Leadership Program (HELP): An Equity of Care Catalyst Development Program
  Award Number: 11455
  Sponsor: FLORIDA BLUE
  de C. (PD/PI), Green, B. (Co-PD/PI), Sanchez, J. (Co-PD/PI)

Voted top doctor in Colon/Rectal Surgery in Tampa Magazine's Top Doctors 2025.

Voted top doctor in Colon/Rectal Surgery in Tampa Magazine's Top Doctors 2024.